Clinical Accelerator is pleased to announce a collaboration with HEPTA Medical, a pioneering medtech company developing next-generation therapeutic solutions for early-stage cancer treatment.

HEPTA Medical is at the forefront of innovation in thermal ablation technology. The company has developed a 𝗺𝗶𝗰𝗿𝗼𝘄𝗮𝘃𝗲 𝗮𝗯𝗹𝗮𝘁𝗶𝗼𝗻 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺 that integrates an 𝗶𝗻-𝘀𝗶𝘁𝘂 𝗽𝗮𝘁𝗲𝗻𝘁𝗲𝗱 𝘁𝗶𝘀𝘀𝘂𝗲 𝘁𝗲𝗺𝗽𝗲𝗿𝗮𝘁𝘂𝗿𝗲 𝘀𝗲𝗻𝘀𝗼𝗿 with proprietary predictive software, enabling 𝗿𝗲𝗮𝗹-𝘁𝗶𝗺𝗲 𝗺𝗼𝗻𝗶𝘁𝗼𝗿𝗶𝗻𝗴 𝗮𝗻𝗱 𝗰𝗼𝗻𝘁𝗿𝗼𝗹 𝗼𝗳 𝗮𝗯𝗹𝗮𝘁𝗶𝗼𝗻 𝗽𝗿𝗼𝗰𝗲𝗱𝘂𝗿𝗲𝘀 during treatment. This cutting-edge approach aims to improve precision and safety in the treatment of cancerous lesions, offering clinicians enhanced feedback throughout the procedure.

Under this collaboration, Clinical Accelerator will support HEPTA Medical in the execution and operational management of early-stage clinical trials that evaluate the safety and performance of their innovative platform. Leveraging our deep expertise in early-stage clinical research and global site networks, we will help accelerate the delivery of clinical evidence required for regulatory milestones and broader clinical adoption.

For more information on HEPTA Medical’s technology and mission, visit https://www.heptamed.com/.